【券商聚焦】第一上海维持香港交易所(00388)买入评级 指当前的估值水平具备坚实的基本面支撑

金吾财讯
Nov 11

金吾财讯 | 第一上海发研报指,9M25香港交易所(00388)实现收入及其他收益219亿港元(同比+37%);归母净利润134亿港元(同比+45%);EBITDA为172亿港元(同比+48%);EBITDA利润率为79%(同比+5pct)。从各个业务板块来看,交易费及交易系统使用费/结算及交收费/联交所上市费/存托管及代理人服务费/市场数据费/其他收入在9M25分别达78/53/13/11/9/14亿港元,同比变化分别为+57%/+66%/+17%/+25%/+8%/+10%。该机构认为港交所当前的估值水平具备坚实的基本面支撑。其核心业务——现货市场、衍生品市场及互联互通机制——均呈现高速增长态势,尤其是港股通,显示出内地资金对香港市场的持续青睐。在战略层面,港交所持续推进市场架构优化,如实施最低上落价位下调、探讨缩短结算周期、推出新产品如恒生生物科技指数期货等,这些举措有望进一步提升市场效率和产品多样性,增强长期竞争力。考虑到港交所独特的市场垄断地位、与市场成交量的高度关联性,以及其业绩在2025年展现出的强劲增长动能,该机构认为其应享有高于市场平均的估值溢价。参考其历史PE区间及可比公司估值,并综合其增长前景,该机构给予港交所2026年38倍PE的估值倍数,对应目标价550港元,较前一收盘价有28%的涨幅,维持买入评级。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10